Daniel F J Ketelhuth Selected Research

Daniel F J Ketelhuth Research Topics

Disease

38	Atherosclerosis 05/2022 - 01/2002
21	Inflammation (Inflammations) 06/2022 - 03/2011
11	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 01/2008
6	Atherosclerotic Plaque (Atheroma) 01/2019 - 04/2011
4	Thrombosis (Thrombus) 01/2019 - 03/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2015
2	Neoplasms (Cancer) 01/2019 - 01/2018
2	Rupture 01/2018 - 03/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 03/2004
2	Hypercholesterolemia 11/2017 - 05/2017
2	Myocardial Infarction 01/2016 - 03/2010
2	Obesity 10/2015 - 06/2013
2	Stroke (Strokes) 01/2015 - 03/2010
2	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 08/2012
1	Non-alcoholic Fatty Liver Disease 05/2022
1	Hepatocellular Carcinoma (Hepatoma) 05/2022
1	Liver Diseases (Liver Disease) 05/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Adenoviridae Infections (Adenovirus Infections) 10/2020
1	Hyperplasia 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Aneurysm (Aneurysms) 01/2019
1	Disease Progression 10/2018
1	ST Elevation Myocardial Infarction 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Infections 01/2016
1	Insulin Resistance 10/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015
1	Rheumatoid Arthritis 01/2015

Drug/Important Bio-Agent (IBA)

11	CholesterolIBA 06/2022 - 05/2012
10	Lipoproteins (Lipoprotein)IBA 06/2022 - 07/2006
9	LipidsIBA 10/2020 - 04/2011
8	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2002
8	LDL Lipoproteins (beta Lipoproteins)IBA 11/2018 - 05/2010
8	oxidized low density lipoproteinIBA 11/2018 - 01/2002
7	Apolipoproteins E (ApoE)IBA 05/2022 - 05/2015
5	ApolipoproteinsIBA 06/2022 - 03/2011
5	KynurenineIBA 05/2022 - 01/2019
4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2022 - 05/2015
4	CytokinesIBA 01/2022 - 03/2011
4	AntibodiesIBA 01/2019 - 03/2004
4	LDL Receptors (LDL Receptor)IBA 05/2017 - 07/2006
3	Tryptophan (L-Tryptophan)FDA Link 10/2020 - 08/2012
3	3-Hydroxyanthranilic AcidIBA 10/2020 - 08/2012
3	Apolipoprotein B-100 (Apo B 100)IBA 11/2018 - 05/2010
3	Matrix Metalloproteinases (MMPs)IBA 09/2015 - 03/2010
3	AntigensIBA 06/2013 - 05/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2015
2	InterferonsIBA 01/2022 - 07/2013
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2011
2	low density lipoprotein inhibitorIBA 01/2018 - 01/2013
2	Biological ProductsIBA 01/2017 - 03/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2016 - 05/2012
2	AutoantigensIBA 02/2016 - 04/2015
2	Phosphorylcholine (Phosphocholine)IBA 01/2016 - 04/2015
2	Glucose (Dextrose)FDA LinkGeneric 10/2015 - 06/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2015 - 07/2013
2	EpitopesIBA 04/2015 - 05/2010
2	Triglycerides (Triacylglycerol)IBA 05/2012 - 01/2002
2	Peptides (Polypeptides)IBA 11/2011 - 05/2010
1	IronIBA 05/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	AngiotensinsIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	Inflammation MediatorsIBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	RotenoneIBA 10/2020
1	AcidsIBA 10/2020
1	InflammasomesIBA 10/2020
1	I-kappa B KinaseIBA 01/2020
1	NF-kappaB-Inducing KinaseIBA 01/2020
1	Pharmaceutical PreparationsIBA 12/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	EnzymesIBA 01/2019
1	Pancreatic Elastase (Elastase)IBA 01/2019
1	canakinumab FDA Link 01/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 10/2018
1	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 10/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2017
1	Immunoglobulin M (IgM)IBA 01/2016
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2016
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2016
1	DNA Repair EnzymesIBA 01/2016
1	Insulin (Novolin)FDA Link 10/2015
1	Leukotriene B4IBA 09/2015
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 09/2015
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015

Therapy/Procedure

5	Therapeutics 06/2022 - 01/2013
1	Secondary Prevention 01/2019
1	Percutaneous Coronary Intervention 01/2018
1	Glycemic Control 10/2015